PUBLISHER: Grand View Research | PRODUCT CODE: 2040775
PUBLISHER: Grand View Research | PRODUCT CODE: 2040775
The global cat therapeutic diet market size was estimated at USD 1.8 billion in 2025 and is projected to reach USD 3.6 billion by 2033, growing at a CAGR of 8.9% from 2026 to 2033. The market growth is driven by continuous innovation in specialized pet nutrition, enabling the development of more effective and condition-specific formulations.
This is further supported by the rising prevalence of chronic diseases in cats, which is increasing the need for targeted dietary interventions. In addition, the ongoing premiumization of pet food products, with a shift toward high-quality, scientifically formulated diets, is also contributing significantly to overall market expansion.
Advancements in microbiome science are playing a critical role in transforming therapeutic nutrition for pets, with leading companies introducing clinically backed innovations. For instance, Hill's Pet Nutrition showcased its latest developments at the Veterinary Meeting & Expo (VMX) 2025, highlighting new and enhanced Prescription Diet and Science Diet products powered by ActivBiome+ technology. This innovation is based on extensive microbiome research involving thousands of biological samples, enabling targeted nutritional interventions that actively support gut health. The technology includes specialized formulations such as ActivBiome+ Digestion for gastrointestinal support, ActivBiome+ Kidney Defense for reducing toxin buildup, and Multi-Benefit blends designed to enhance immune and organ health.
Moreover, the increasing prevalence of chronic and nutrition-related diseases in cats is significantly driving the demand for specialized dietary interventions. For instance, according to an article published by SKS Veterinary Hospital, in October 2025, among the conditions, obesity has emerged as one of the most common and clinically complex disorders in companion animals, particularly in urban environments where prevalence rates are estimated to reach 35-40%. Beyond excess weight, obesity is associated with metabolic dysfunction, hormonal imbalance, and a higher risk of secondary conditions such as diabetes, joint disorders, and cardiovascular complications. Although adoption is still evolving, there is a growing opportunity for clinically formulated weight-management diets, with around 35% of cat owners already incorporating therapeutic or prescription diets into their pets' weight-loss programs.
Moreover, according to an article published by Merck & Co., Inc., diabetes is an increasingly recognized metabolic disorder in pets, affecting approximately 1 in 230 cats. This growing prevalence highlights the need for early diagnosis and structured disease management, as diabetes requires long-term control through a combination of veterinary care and specialized nutrition. This gap between disease prevalence and treatment adoption highlights a strong growth potential for the cat therapeutic diet industry. As veterinary awareness and diagnostic rates improve, there is a growing shift toward structured, diet-based management of obesity and its related conditions.
Furthermore, the increasing adoption of pet insurance is creating a strong opportunity for the cat therapeutic diet industry by improving affordability and encouraging veterinary-led treatment. For instance, policies offered through Asda Money cover veterinary consultations, diagnostics, medications, and treatments for new illnesses or injuries, which increases the likelihood of early diagnosis and clinical intervention. Importantly, these policies also include specialist or prescribed diet food under veterinary fee cover, typically within defined limits depending on the plan. This means that for conditions like GI issues, renal disease, or allergies, a portion of the cost of therapeutic or prescription diets may be covered as part of treatment, easing the financial burden on pet owners.
Global Cat Therapeutic Diet Market Report Segmentation
This report forecasts revenue growth at global, regional, and country levels and provides an analysis of the latest industry trends in each of the sub-segments from 2021 to 2033. For this study, Grand View Research has segmented the global cat therapeutic diet market report based on product, indication, distribution channel, and region.